These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16430616)

  • 1. Real-time multiple microsensor tissue recognition and its potential application in the management of prostate cancer.
    Kommu SS; Andrews RJ; Mah RW
    BJU Int; 2006 Feb; 97(2):222-3. PubMed ID: 16430616
    [No Abstract]   [Full Text] [Related]  

  • 2. CyberKnife in the treatment of prostate cancer: a revolutionary system.
    Morgia G; De Renzis C
    Eur Urol; 2009 Jul; 56(1):40-2. PubMed ID: 19246151
    [No Abstract]   [Full Text] [Related]  

  • 3. Real-time elastography for the diagnosis of prostate cancer: evaluation of elastographic moving images.
    Miyagawa T; Tsutsumi M; Matsumura T; Kawazoe N; Ishikawa S; Shimokama T; Miyanaga N; Akaza H
    Jpn J Clin Oncol; 2009 Jun; 39(6):394-8. PubMed ID: 19359330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic prostate surgery.
    Muntener M; Ursu D; Patriciu A; Petrisor D; Stoianovici D
    Expert Rev Med Devices; 2006 Sep; 3(5):575-84. PubMed ID: 17064243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation.
    Da Pozzo L; Scattoni V; Mazzoccoli B; Rigatti P; Manferrari F; Martorana G; Pietropaolo F; Belgrano E; Prezioso D; Lotti T; Villari D; Nicita G
    BJU Int; 2007 Nov; 100(5):1055-9. PubMed ID: 17711511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosensor developments: application to prostate-specific antigen detection.
    Healy DA; Hayes CJ; Leonard P; McKenna L; O'Kennedy R
    Trends Biotechnol; 2007 Mar; 25(3):125-31. PubMed ID: 17257699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical technologies for the diagnosis of prostate cancer.
    Fitzsimons NJ; Sun L; Moul JW
    Expert Rev Med Devices; 2007 Mar; 4(2):227-39. PubMed ID: 17359227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apical soft tissue biopsies predict biochemical failure in radical perineal prostatectomy patients with apical cancer involvement.
    Kübler HR; Szukala SA; Madden JF; Tseng TY; Paulson DF; Vieweg J; Dahm P
    Prostate Cancer Prostatic Dis; 2007; 10(1):72-6. PubMed ID: 17179978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prototype biosensor-integrated image-guided surgery system.
    Reisner LA; King BW; Klein MD; Auner GW; Pandya AK
    Int J Med Robot; 2007 Mar; 3():82-8. PubMed ID: 17441030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate biopsy strategies.
    Presti JC
    Nat Clin Pract Urol; 2007 Sep; 4(9):505-11. PubMed ID: 17823604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-marking scheme for a cost-effective extended prostate biopsy protocol.
    Firoozi F; Nazeer T; Fisher HA; Kaufman RP; White MD; Mian BM
    Urol Oncol; 2009; 27(1):21-5. PubMed ID: 18367125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
    Philip J
    Eur Urol; 2008 May; 53(5):981-2. PubMed ID: 17997013
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach.
    Andriole GL; Bullock TL; Belani JS; Traxel E; Yan Y; Bostwick DG; Humphrey PA
    Urology; 2007 Dec; 70(6 Suppl):22-6. PubMed ID: 18194707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.
    Schröder FH; Bangma CH; Roobol MJ
    Eur Urol; 2008 May; 53(5):901-8. PubMed ID: 18262712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland.
    Matsumoto K; Egawa S; Satoh T; Kuruma H; Yanagisawa N; Baba S
    Int J Urol; 2006 Oct; 13(10):1290-5. PubMed ID: 17010007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
    Patel A
    Eur Urol; 2008 May; 53(5):982-3. PubMed ID: 17997023
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed diagnosis of prostate cancer with neuroendocrine differentiation after laser TURP.
    Meeks JJ; Habermacher GM; Le B; Smith ND
    Urology; 2008 Oct; 72(4):948.e11-2. PubMed ID: 18342929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate cancer detection by prostate biopsy among Japanese with prostate-specific antigen below 4.0 ng/ml].
    Kanno T; Shibasaki N; Tsuji Y; Taki Y; Takeuchi H
    Hinyokika Kiyo; 2006 Mar; 52(3):181-4. PubMed ID: 16617870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.